Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.

Intra-Cellular Therapies' CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar de ...

Cegeka, a Microsoft Business Applications Inner Circle member and leading technology partner, today announced its expansion into the pharmaceutical and life sciences markets in the Americas with a ...

The largest life sciences association in the state recognized those driving discovery during its 32nd annual dinner meeting ...

As detailed in our previous updates, the IRA’s Medicare Drug Price Negotiation Program (the Negotiation Program or Program), ...

Tennessee IT specialist Bradley Dawson gets life in prison for the murder of pharmacist wife Christe Chen on their honeymoon ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

Teva Pharmaceuticals, the world's largest manufacturer of generic ... more than 75% of the potential new tariffs paid by companies in Indiana. The state of New Jersey also has significant exposure, ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Axsome Therapeutics, Inc.'s' stock surges 30% amid key catalysts. Learn why it's now rated a Buy wih upcoming data opportunities. Click for my AXSM update.

The success of Epidiolex prompted several companies to attempt to create generic versions. Jazz Pharmaceuticals plc (NASDAQ: ...